IO Biotech, Inc. (IOBTQ)
OTCMKTS · Delayed Price · Currency is USD
0.00305
+0.00005 (1.67%)
At close: May 22, 2026
IO Biotech Stock Forecast
OTC-IOBTQ's stock price has decreased by -99.73% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover IO Biotech stock have a consensus rating of "Sell" and an average price target of $0.43, which forecasts a 13,998.36% increase in the stock price over the next year. The lowest target is $0.36 and the highest is $0.50.
Price Target: $0.43 (+13,998.36%)
Analyst Consensus: Sell
No price target forecast data available
* Price targets were last updated on Jan 23, 2026.
Analyst Ratings
The average analyst rating for IO Biotech stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 2 | 2 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 0 |
| Total | 5 | 5 | 4 | 4 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Downgrades $3 → $0.5 | Hold | Downgrades | $3 → $0.5 | +16,293.44% | Jan 23, 2026 |
| Morgan Stanley | Morgan Stanley | Sell Downgrades $0.39 → $0.36 | Sell | Downgrades | $0.39 → $0.36 | +11,703.28% | Jan 8, 2026 |
Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.